Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Tyniec Maly, Poland Clinical Trials

A listing of Tyniec Maly, Poland clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

A Study to Evaluate the Efficacy Safety and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

At Screening (Visit 1), subjects will enter into a 4-week open label tamsulosin hydrochloride 0.4 mg QD run-in period prior to being randomized into the 12-week double-blind treatment period (Visit 2). At conclusion of the 4-week tamsulosin hydrochloride run-in period, subjects will complete a 3-day diary just prior to Baseline ...

Phase

5.58 miles

Learn More »

This is a randomized, double-blind, placebo-controlled, multicenter phase III study. The study population will consist of approximately 1300 subjects with metastatic hormone sensitive prostate cancer (mHSPC), who will be randomized (1:1 ratio) to receive 600 mg (2 x 300 mg tablets) of darolutamide (ODM-201)/placebo twice daily with food, equivalent to ...

Phase

6.41 miles

Learn More »

Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated

Additional objectives of the study for high-risk (non-metastatic) prostate cancer patients are as follows: Analysis of number of circulating tumor cells in peripheral blood as a prognostic/predictive factors for survival. Analysis of miRNA expression levels (100, 141 and 143) in peripheral blood as a prognostic and predictive factors. Evaluation of ...

Phase N/A

6.73 miles

Learn More »

Association of Multiple CardiOvascular Risk Factors and Erectile Function Across Europe

Association of cardiovascular risk factors and ED is likely due to an impairment of endothelial function resulting in a decreased activity of endothelial NO-synthase, which plays a major role in physiology of erection. Heart failure is also known to further contribute to endothelial dysfunction and hence, this could lead to ...

Phase N/A

8.01 miles

Learn More »

BAY81-8973 Pediatric Safety and Efficacy Trial

The objective of the study is to demonstrate the safety and efficacy of treatment with BAY81-8973 for prophylaxis and breakthrough bleeds in children with severe haemophilia A.

Phase

9.21 miles

Learn More »